<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017955"><a href="http://purl.obolibrary.org/obo/MONDO_0017955">MONDO:0017955</a></h3>
<p><strong>Label:</strong> granulomatous autoinflammatory syndrome</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019338">MONDO:0019338</a> (sarcoidosis),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_612387">OMIM:612387</a>, <a href="http://purl.obolibrary.org/obo/OMIM_181000">OMIM:181000</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612388">OMIM:612388</a>, <a href="http://www.orpha.net/ORDO/Orphanet_797">Orphanet:797</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0100828">HP:0100828</a> (Increase in T cell count) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100828">HP:0100828</a> (Increase in T cell count) and <a href="http://purl.obolibrary.org/obo/HP_0410042">HP:0410042</a> (Abnormal liver morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100828">HP:0100828</a> (Increase in T cell count) and <a href="http://purl.obolibrary.org/obo/HP_0200036">HP:0200036</a> (Skin nodule) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100828">HP:0100828</a> (Increase in T cell count) and <a href="http://purl.obolibrary.org/obo/HP_0200035">HP:0200035</a> (Skin plaque) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100827">HP:0100827</a> (Lymphocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0410042">HP:0410042</a> (Abnormal liver morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100827">HP:0100827</a> (Lymphocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0200036">HP:0200036</a> (Skin nodule) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100827">HP:0100827</a> (Lymphocytosis) and <a href="http://purl.obolibrary.org/obo/HP_0200035">HP:0200035</a> (Skin plaque) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) and <a href="http://purl.obolibrary.org/obo/HP_0100828">HP:0100828</a> (Increase in T cell count) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100749">HP:0100749</a> (Chest pain) and <a href="http://purl.obolibrary.org/obo/HP_0100828">HP:0100828</a> (Increase in T cell count) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100749">HP:0100749</a> (Chest pain) and <a href="http://purl.obolibrary.org/obo/HP_0100827">HP:0100827</a> (Lymphocytosis) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100699">HP:0100699</a> (Scarring) and <a href="http://purl.obolibrary.org/obo/HP_0100828">HP:0100828</a> (Increase in T cell count) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100699">HP:0100699</a> (Scarring) and <a href="http://purl.obolibrary.org/obo/HP_0100827">HP:0100827</a> (Lymphocytosis) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100533">HP:0100533</a> (Inflammatory abnormality of the eye) and <a href="http://purl.obolibrary.org/obo/HP_0100828">HP:0100828</a> (Increase in T cell count) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100533">HP:0100533</a> (Inflammatory abnormality of the eye) and <a href="http://purl.obolibrary.org/obo/HP_0100827">HP:0100827</a> (Lymphocytosis) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0040186">HP:0040186</a> (Maculopapular exanthema) and <a href="http://purl.obolibrary.org/obo/HP_0100828">HP:0100828</a> (Increase in T cell count) 62.50%</li>
</ul>
</body>
</html>
